Overview
Renishaw plc is a British engineering company specializing in precision measurement and healthcare products, renowned for its contributions to metrology and spectroscopy. Despite a global presence, the company maintains central operations in the United Kingdom. Renishaw is deeply engaged in the development and manufacturing of advanced measurement systems critical to high-precision sectors, including automotive, aerospace, and industrial automation. In healthcare, the company innovatively applies its measurement expertise to create unique assistive technologies, ensuring precise surgical procedures and diagnostics. Its key projects often involve pioneering new applications of metrology in both industrial and clinical settings, contributing significantly to advancements in these fields. Throughout its operations, Renishaw emphasizes innovation, quality, and continuous improvement, aligning its strategic objectives with industry needs and technological progress.
AI+ Ask Fintel’s AI assistant about Renishaw plc.
Thinking about good questions…
Basic Stats
The share price of Renishaw plc as of May 24, 2024 is $51.04 / share.
The Factor Analysis chart (below right) shows a view of Renishaw plc from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 0.00 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | 2025-03-06 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Renishaw plc is $49.69. The forecasts range from a low of $39.52 to a high of $66.26. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Renishaw plc. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-06-12 | Jefferies | Underperform | Reiterate | |
| 2023-05-03 | Barclays | Underweight | Reiterate | |
| 2023-02-06 | Barclays | Underweight | Reiterate | |
| 2022-10-06 | Barclays | Underweight | Reiterate | |
| 2022-07-20 | Barclays | Underweight | Reiterate | |
| 2022-05-13 | Berenberg Bank | Buy | Reiterate | |
| 2022-02-15 | Barclays | Underweight | Reiterate | |
| 2022-02-15 | Barclays | Reiteration | Reiterate | |
| 2022-02-01 | Barclays | Reiteration | Reiterate | |
| 2021-11-17 | Berenberg Bank | Reiteration | Reiterate | |
| 2021-10-27 | Morgan Stanley | Equal-weight | Reiterate | |
| 2021-10-25 | Barclays | Underweight | Reiterate | |
| 2021-07-20 | Barclays | Underweight | Reiterate | |
| 2021-02-05 | Barclays | Underweight | Reiterate | |
| 2021-02-04 | Berenberg Bank | Buy | Reiterate | |
| 2020-05-18 | Barclays | Underweight | Reiterate | |
| 2019-10-15 | Peel Hunt LLP | Reduce | Reiterate | |
| 2019-05-17 | Numis | Hold | Reiterate | |
| 2019-01-21 | Deutsche Bank | Sell | Reiterate | |
| 2018-12-05 | Morgan Stanley | Equal-weight | Reiterate | |
| 2017-03-13 | UBS | Neutral | Reiterate | |
| 2016-08-18 | UBS | Neutral | Reiterate | |
| 2016-02-11 | Investec | Hold | Reiterate | |
| 2016-01-29 | Numis | Buy | Reiterate | |
| 2016-01-28 | Investec | Hold | Reiterate | |
| 2015-11-18 | UBS | Neutral | Reiterate | |
| 2015-10-15 | N+1 Singer | Sell | Reiterate | |
| 2015-10-08 | Investec | Hold | Reiterate | |
| 2015-10-06 | Credit Suisse | Neutral | Reiterate | |
| 2015-08-18 | Credit Suisse | Neutral | Reiterate | |
| 2015-07-30 | Numis | Buy | Reiterate | |
| 2015-05-15 | Numis Securities | Add | Reiterate | |
| 2015-03-24 | Credit Suisse | Neutral | Reiterate | |
| 2015-02-10 | Numis Securities | Hold | Reiterate | |
| 2015-02-10 | N+1 Singer | Sell | Reiterate | |
| 2015-02-02 | N+1 Singer | Sell | Reiterate | |
| 2015-01-30 | UBS | Neutral | Reiterate | |
| 2015-01-29 | N+1 Singer | Sell | Reiterate | |
| 2015-01-12 | Investec | Hold | Reiterate | |
| 2015-01-08 | UBS | Neutral | Reiterate | |
| 2015-01-07 | Barclays | Overweight | Reiterate | |
| 2015-01-07 | Numis Securities | Add | Reiterate | |
| 2015-01-07 | N+1 Singer | Hold | Reiterate | |
| 2014-12-17 | Credit Suisse | Neutral | Reiterate | |
| 2014-11-12 | UBS | Neutral | Reiterate | |
| 2014-11-04 | N+1 Singer | Hold | Reiterate | |
| 2014-10-27 | Investec | Buy | Reiterate | |
| 2014-10-27 | N+1 Singer | Hold | Reiterate | |
| 2014-10-20 | Numis Securities | Add | Reiterate | |
| 2014-10-13 | Investec | Buy | Reiterate | |
| 2014-10-03 | N+1 Singer | Hold | Reiterate | |
| 2014-08-21 | Investec | Buy | Reiterate | |
| 2014-08-08 | Credit Suisse | Neutral | Reiterate | |
| 2014-07-24 | UBS | Neutral | Reiterate | |
| 2014-07-23 | Investec | Buy | Reiterate | |
| 2014-05-29 | Investec | Hold | Reiterate | |
| 2014-05-19 | UBS | Neutral | Reiterate | |
| 2014-05-14 | Numis Securities | Hold | Reiterate | |
| 2014-05-14 | N+1 Singer | Hold | Reiterate | |
| 2014-05-12 | Barclays | Overweight | Reiterate | |
| 2014-01-31 | UBS | Neutral | Reiterate | |
| 2013-12-12 | Credit Suisse | Neutral | Reiterate | |
| 2013-09-18 | Investec | Hold | Reiterate | |
| 2013-08-21 | Investec | Hold | Reiterate | |
| 2013-07-24 | Numis Securities | Hold | Reiterate | |
| 2013-07-10 | Goldman Sachs | Buy | Reiterate | |
| 2013-07-03 | Citigroup | Sell | Reiterate | |
| 2013-07-02 | UBS | Neutral | Reiterate | |
| 2013-07-01 | Investec | Hold | Reiterate | |
| 2013-06-18 | Credit Suisse | Neutral | Reiterate | |
| 2024-09-13 | Deutsche | Hold | Reiterate | |
| 2025-09-05 | UBS | Buy | Reiterate | |
| 2025-09-05 | Deutsche | Hold | Reiterate |
